Cytena develops single-cell printing technology for cell research and professional diagnostics.
Cytena has raised €3.0M across 1 funding round from 1 investor, most recently a Series A round in Jan 2019. Based in Freiburg, Germany; founded 2014; active in Healthtech. Acquired by CELLINK in 2019. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A | €3.0M | High-Tech Gründerfonds | View deal → |
